Rockwell Medical (RMTI) Liabilities and Shareholders Equity (2010 - 2026)

Rockwell Medical's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $57.4 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 6.42% year-over-year to $57.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $224.7 million (up 0.63% YoY) and the FY2025 annual result came in at $57.1 million, down 3.48% from the prior year.
• Liabilities and Shareholders Equity was $57.4 million for Q1 2026 at Rockwell Medical, roughly flat from $57.1 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $59.2 million in Q4 2024 and bottomed at $37.4 million in Q1 2022.
• A 5-year average of $51.7 million and a median of $53.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity plunged 46.1% — and 2024, when it jumped 39.41%.
• Rockwell Medical's Liabilities and Shareholders Equity stood at $46.6 million in 2022, then climbed by 11.88% to $52.2 million in 2023, then gained by 13.48% to $59.2 million in 2024, then dropped by 3.48% to $57.1 million in 2025, then climbed by 0.49% to $57.4 million in 2026.
• Business Quant data shows RMTI's Liabilities and Shareholders Equity at $57.4 million in Q1 2026, $57.1 million in Q4 2025, and $57.5 million in Q3 2025.